Skip to main content
See every side of every news story
Published • loading... • Updated

China Could ‘Corner’ Biopharmaceutical Sector with New Plan, US Panel Warns

The commission says 57 deals since early 2023 are shifting capital and know-how toward Chinese firms and could deepen U.S. dependence on drug supplies.

A commission called on U.S. lawmakers to act quickly to prevent an “overdependence” on China that could leave American patients “vulnerable to supply chain weaponization.”

9 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 66% of the sources lean Right
66% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Axios broke the news in Arlington, United States on Thursday, November 19, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal